MondegarAI
Long Corridor Asset Management Ltd

Q3 2024 · 13F-HR

Long Corridor Asset Management Ltdholdings as filed

Filed 2024-11-12 · accession 0001845501-24-000005

$113.5M
Reported value
20
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
30303M102METAMETA PLATFORMS INC$18.9M16.6%33,000CommonSOLE
090040AF3BILI 0.5 12/01/26BILIBILI INC$15.9M14.0%16,000,000CommonSOLE
02079K305GOOGLALPHABET INC$14.9M13.2%90,000CommonSOLE
948596101WBWEIBO CORP$12.0M10.6%924,904CommonSOLE
01609W102BABAALIBABA GROUP HLDG LTD$10.6M9.35%100,000CommonSOLE
62914VAF3NIO 0.5 02/01/27NIO INC$8.8M7.74%9,000,000CommonSOLE
025816109AXPAMERICAN EXPRESS CO$6.8M5.97%25,000CommonSOLE
07725L102ONCBEIGENE LTD$5.8M5.10%25,755CommonSOLE
81141R100SESEA LTD$5.7M4.98%60,000CommonSOLE
66981J102MNSOMINISO GROUP HLDG LTD$4.0M3.52%227,997CommonSOLE
98954M101ZGZILLOW GROUP INC$3.5M3.07%56,249CommonSOLE
650111107NYTNEW YORK TIMES CO$1.7M1.47%30,000CommonSOLE
18539C105NY4BCLEARWAY ENERGY INC$1.6M1.38%54,732CommonSOLE
98422D105XPEVXPENG INC$1.5M1.36%126,847CommonSOLE
005083100ACTUACTUATE THERAPEUTICS INC$931,2500.82%125,000CommonSOLE
230031106CGEMCULLINAN THERAPEUTICS INC$251,1000.22%15,000CommonSOLE
61225M102GLUEMONTE ROSA THERAPEUTICS INC$212,0000.19%40,000CommonSOLE
50127T109KURAKURA ONCOLOGY INC$195,4000.17%10,000CommonSOLE
87164F105SNDXSYNDAX PHARMACEUTICALS INC$192,5000.17%10,000CommonSOLE
68217N105OMEGA THERAPEUTICS INC$103,7000.09%85,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.